Meetings
John’s Top Recurring Meetings
Virtual meetings are easy to attend, but regular attendance at annual in-person events is the key to building your network and gaining deeper insight. My personal favorites for such in-person meetings are below. Of particular value for developers, the small meeting format of BEAM’s AMR Conference (March) and GAMRIC (September-October; formerly, the ESCMID-ASM conference series) creates excellent global networking. IDWeek (October) and ECCMID (April) are much larger meetings but also provide opportunities for networking with a substantial, focused audience via their Pipeline sessions. Hope to see you there!
- 21-24 Oct 2026 (Washington, DC, USA): IDWeek 2026, the annual meeting of the Infectious Diseases Society of America. I would expect the program to continue to provide a substantial opportunity to present a product to a large audience (see also adjacent note about ESCMID) as well as opportunities to present at an IDWeek Pipeline Session. Go here to register.
- 23-24 Mar 2027 (Basel, Switzerland): The 10th AMR Conference (3-4 Mar 2026) is now over and offered a rich program that included a 10-year retrospective (we’ve done a lot!), regulatory updates, discussions of how to pursue development in China, and much more … in addition to being a superb opportunity for networking! You can review the content on the conference website; the 2027 program should post relatively soon.
- 9-13 April 2027 (Stockholm, Sweden): ESCMID Global 2027, the annual meeting of the European Society for Clinical Microbiology and Infectious Diseases. Details won’t be out for some months, but the website is here. I do know that the meeting schedule will again include a Science Policy Forum on Friday 9 April 2027 (see here the newsletter about the 2026 science policy forum) and all who are interested in Pull incentives and the antibiotic ecosystem should plan to be there!)..
- [NEW] 7-9 Sep 2027 (Bangalore, India): The 3nd GAMRIC, the Global AMR Innovators Conference. Formerly the ESCMID-ASM (or ASM-ESCMID depending on location) Joint Conference on Drug Development for AMR, 2027 will be the 12th year for this series that is now under the joint sponsorship of CARB-X, ESCMID, LifeArc,GARDP, BEAM Alliance, Boston University, and AMR.Solutions. The 2026 meeting in Lisbon was superb and included substantial networking time (drinks on the lawn!), a keynote lecture by Karen Bush on the threat to beta-lactams due to the emergence of PBP3 mutations and sessions on program design for phage, development for pediatrics, and more. You can expect similar quality in 2027! Mark your calendar — details to follow in the spring of 2027!
Upcoming meetings of interest to the AMR community:
- 21-24 Oct 2026 (Washington, DC, USA): IDWeek 2026. See list of Top Recurring meetings, above.
- [NEW] 27 Oct 2026 (virtual, 7-8a EDT): GARDP webinar entitled “From approval to access: A new model for delivering effective antibiotics.” The focus is a discussion of “the challenges surrounding antibiotic access for various populations, including high-burden populations.” Go here to register.
- 10-13 November 2026 (Madrid, Spain): The International Society for Infectious Diseases (ISID) has announced its 21st International Congress on Infectious Diseases (ICID). Regular registration rates for ICID 2026 are available through September 30, 2026. Register and view the preliminary program here.
- 16-18 Nov 2026 (FAO Headquarters, Viale delle Terme di Caracalla, 00153 Rome, Italy): The 4th Annual Plenary Assembly of the AMR Multi-Stakeholder Partnership Platform, of the Quadripartite organizations (FAO, UNEP, WHO, and WOAH). “Organized ahead of the Fifth High-Level Ministerial Conference on AMR, the Plenary Assembly will bring together MSPP members and observers, partners and external stakeholders from across regions and One Health sectors. The Plenary Assembly will focus on moving from political commitments to practical delivery, with particular attention to supporting countries in implementing their AMR NAPs.” Go here for additional details to register.
- 27-29 Jan 2027 (Las Vegas, USA): IMARI (Interdisciplinary Meeting on Antimicrobial Resistance and Innovation) sponsored by IDSA and ASM. Abstract submissions are open through 19 Aug; registration and housing will open later this summer.
- [NEW] 4 Feb 2027 (in person, Liverpool, UK): Bionow‘s Bioinfect 2027 Conference on AMR. Good networking! Go here for details and to register.
- 9-11 Feb 2027 (virtual, 1-5p GMT each day): ACC2027 (Antimicrobial Chemotherapy Conference 2027), sponsored by GARDP and BSAC (British Society for Antimicrobial Chemotherapy) in collaboration with EUP OHAMR (European Partnership on One Health Antimicrobial Resistance). This 3-day online conference includes both symposia and poster presentations. Go here for details and to register.
- 23-24 Mar 2027 (Basel, Switzerland): The 11th AMR Conference sponsored by the BEAM Alliance. See list of Top Recurring meetings, above.
- 9-13 April 2027 (Stockholm, Sweden): ESCMID Global 2026, the annual meeting of the European Society for Clinical Microbiology and Infectious Diseases. See Recurring Meetings list, above.
- 7-9 Sep 2027 (Bangalore, India): GAMRIC the Global AMR Innovators Conference. See list of Top Recurring meetings, above..
- [Placeholder] ??? Oct 2027 (Annecy, France, residential in-person program): ICARe (Interdisciplinary Course on Antibiotics and Resistance). This will be year 11 for this course. Patrice Courvalin orchestrates content with the support of an all-star scientific committee and faculty. The resulting soup-to-nuts training covers all aspects of antimicrobials, is very intense, and routinely gets rave reviews! For now, just keep it mind for that timeframe … I will add 2027 details when Patrice recovers from running the 2026 program and posts the dates for next year!
- [Placeholder] ??? Mar 2028 (yes, that’s 2028, with location TBD): The 2028 Gordon Research Conference (GRC, https://www.grc.org/) entitled “Antibacterials of Tomorrow to Combat the Global Threat of Antimicrobial Resistance” and its related Gordon Research Seminar (GRS) for young doctoral and post-doctoral researchers will be sometime in March 2028. The organizers hope to coordinate dates and location with the 2028 BEAM-AMR meeting. Details to follow — mark your calendar!
Self-paced courses, online training materials, and other reference materials:
- [NEW] The COMBINE Pneumonia Model is a standardized murine lung infection model designed for preclinical evaluation of novel small-molecule antibiotics. The model combines a consensus lung infection protocol with a repository of well-characterized, strains of Klebsiella pneumoniae and Pseudomonas aeruginosa that are available through the DSMZ (IMI COMBINE Preclinical Bacterial Strain Repository). Developed by the Innovative Medicines Initiative COMBINE project, the model provides a framework for antibiotic efficacy studies and helps provide consistency across preclinical research.
- OpenWHO: “Antimicrobial Resistance in the environment: key concepts and interventions.” Per the webpage for the course, it will teach you “…why addressing AMR in the environment is essential and gain insights into how action can be taken to prevent and control AMR in the environment at the national level.” This course builds on WHO’s 2024 Guidance on wastewater and solid waste management for manufacturing of antibiotics. For further reading, see also the 25 Sep 2023 newsletter entitled “Manufacturing underpins both access and stewardship: Cefiderocol as a case study” and the 28 Jan 2024 newsletter entitled “EMA Concept Paper: Guidance on manufacturing of phage products”.
- GARDP’s REVIVE website provides an encyclopedia covering a range of R&D terms, recordings of prior GARDP webinars, a variety of viewpoint articles, and more! Check it out!
- GARDP’s https://antibioticdb.com/ is an open-access database of antibacterial agents.
- The CARB-X website provides a range of recordings from its webinars, bootcamps, and more. A bit of browsing would be time well spent!
- British Society for Antimicrobial Chemotherapy offers an eLearning section: Education – The British Society for Antimicrobial Chemotherapy.
Updated on
Share
NIAID/DMID’s 2027 BAA calls for antibacterial and antifungal therapeutics
Dear All: NIAID/DMID have released their 2027 Omnibus Broad Agency Announcement (BAA) entitled “Development of Medical Interventions for Infectious Diseases.” The key starting point is
#AMRSOS: Imipenem-relebactam withdrawn from the US market
Dear All: Oh, no! Hot on the heels of the excellent talk at GAMRIC by Karen Bush in which the importance of relebactam as one
Global Review of Pull Incentives / PASTEUR Sign-On Letter
Dear All: We need to make Pull incentives work! On this theme, our first topic for today is an opportunity for organizations to sign a
CARB-X: 2nd 2026 application call; 5x impact of CARB-X funding!
Dear All: CARB-X have just announced their 2nd 2026 call for applications. There are 4 thematic areas for your proposals: Direct-acting therapeutics for infections caused